Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
Samer A. Srour, Harjeet Singh, Jessica M McCarty, Elenanor De Groot, Helen Huls, Gabriela Rondón, Muzaffar H. Qazilbash, Stefan O. Ciurea, Geraldine Bardelli, Jill Buck, Amin M. Alousi, Yago Nieto, Katayoun Rezvani, David Marín, Uday Popat, Chitra Hosing, Elizabeth J. Shpall, William G. Wierda, Hagop M. Kantarjian, Richard E. Champlin, Laurence J.N. Cooper, Partow Kebriaei
Topics & Concepts
MedicineCD19Refractory (planetary science)Term (time)CAR T-cell therapyOncologyInternal medicineImmunologyChimeric antigen receptorImmunotherapyBiologyCancerAntibodyQuantum mechanicsPhysicsAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research